| Pregnancy |
1 |
1 |
| Biologic Therapy |
0 |
0.99 |
| Fertility |
0 |
0.45 |
| Food and Drug Administration (FDA) |
0 |
0.45 |
| Lactation |
0 |
0.45 |
| Congenital Anomaly |
0 |
0.41 |
| Birth |
0 |
0.36 |
| Child |
0 |
0.36 |
| Pediatric Dermatology |
0 |
0.98 |
| Arkansas |
0 |
0.18 |
| Clinical Guidelines |
0 |
0.18 |
| Anti-Tumor Necrosis Factor (Anti-TNF) |
0 |
0.15 |
| Vaccines |
0 |
0.11 |
| Antineoplastic Drug |
0 |
0.09 |
| Arthritis |
0 |
0.09 |
| Breastfeeding |
0 |
0.09 |
| California |
0 |
0.09 |
| Europe |
0 |
0.09 |
| Hospital |
0 |
0.09 |
| Interleukin |
0 |
0.09 |
| Medical Literature |
0 |
0.09 |
| Mesh |
0 |
0.09 |
| Monoclonal Antibody |
0 |
0.09 |
| Nonprofit Organizations |
0 |
0.09 |
| Preconception |
0 |
0.09 |
| Prescription Drugs |
0 |
0.09 |
| Tumor |
0 |
0.09 |
| Psoriasis |
0 |
0.07 |
| Crohn Disease |
0 |
0.06 |
| Rheumatoid Arthritis |
0 |
0.05 |
| Diarrhea |
0 |
0.04 |
| Inflammatory Bowel Disease |
0 |
0.04 |
| Rotavirus |
0 |
0.04 |